Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8703132 Bispecific, tetravalent antigen binding proteins

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Juergen Michael Schanzer0

Sabine Imhof-Jung0

Wolfgang Schaefer0

Christian Klein0

Joerg Thomas Regula0

Date of Patent

April 22, 2014

0

Patent Application Number

127864770

Date Filed

May 25, 2010

0

Patent Citations Received

US Patent 12103982 T cell activating bispecific antigen binding molecules

0

US Patent 11780920 Antibodies binding to CD3 and CD19

US Patent 11866498 Bispecific antigen-binding molecules and methods of use

0

US Patent 11965025 Method of treating solid cancers with bispecific interleukin-anti-TCRß molecules

0

US Patent 11965030 Multispecific binding proteins with mutant fab domains

0

Patent Primary Examiner

Laura B Goddard

0

Patent abstract

The present invention relates to bispecific, tetravalent antigen binding proteins, methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8703132 Bispecific, tetravalent antigen binding proteins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool